Dravet Syndrome Thereapeutics Market, Global Outlook and Forecast 2022-2028

March 2022 | 65 pages | ID: D947524C723CEN
Market Monitor Global

Abstracts

This report contains market size and forecasts of Dravet Syndrome Thereapeutics in Global, including the following market information:

Global Dravet Syndrome Thereapeutics Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global Dravet Syndrome Thereapeutics market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

BIS-001 Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Dravet Syndrome Thereapeutics include Biscayne Pharmaceuticals, Inc., GW Pharmaceuticals Plc, INSYS Therapeutics, Inc., OPKO Health, Inc., PTC Therapeutics, Inc., Sage Therapeutics, Inc., Xenon Pharmaceuticals Inc. and Zogenix, Inc., etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Dravet Syndrome Thereapeutics companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Dravet Syndrome Thereapeutics Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Dravet Syndrome Thereapeutics Market Segment Percentages, by Type, 2021 (%)

• BIS-001
• Cannabidiol
• CUR-1916
• SAGE-217
• Others

Global Dravet Syndrome Thereapeutics Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Dravet Syndrome Thereapeutics Market Segment Percentages, by Application, 2021 (%)

• Clinic
• Hospital
• Others

Global Dravet Syndrome Thereapeutics Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Dravet Syndrome Thereapeutics Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Dravet Syndrome Thereapeutics revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies Dravet Syndrome Thereapeutics revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Biscayne Pharmaceuticals, Inc.
• GW Pharmaceuticals Plc
• INSYS Therapeutics, Inc.
• OPKO Health, Inc.
• PTC Therapeutics, Inc.
• Sage Therapeutics, Inc.
• Xenon Pharmaceuticals Inc.
• Zogenix, Inc.

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Dravet Syndrome Thereapeutics Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Dravet Syndrome Thereapeutics Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL DRAVET SYNDROME THEREAPEUTICS OVERALL MARKET SIZE

2.1 Global Dravet Syndrome Thereapeutics Market Size: 2021 VS 2028
2.2 Global Dravet Syndrome Thereapeutics Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Dravet Syndrome Thereapeutics Players in Global Market
3.2 Top Global Dravet Syndrome Thereapeutics Companies Ranked by Revenue
3.3 Global Dravet Syndrome Thereapeutics Revenue by Companies
3.4 Top 3 and Top 5 Dravet Syndrome Thereapeutics Companies in Global Market, by Revenue in 2021
3.5 Global Companies Dravet Syndrome Thereapeutics Product Type
3.6 Tier 1, Tier 2 and Tier 3 Dravet Syndrome Thereapeutics Players in Global Market
  3.6.1 List of Global Tier 1 Dravet Syndrome Thereapeutics Companies
  3.6.2 List of Global Tier 2 and Tier 3 Dravet Syndrome Thereapeutics Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 by Type - Global Dravet Syndrome Thereapeutics Market Size Markets, 2021 & 2028
  4.1.2 BIS-001
  4.1.3 Cannabidiol
  4.1.4 CUR-1916
  4.1.5 SAGE-217
  4.1.6 Others
4.2 By Type - Global Dravet Syndrome Thereapeutics Revenue & Forecasts
  4.2.1 By Type - Global Dravet Syndrome Thereapeutics Revenue, 2017-2022
  4.2.2 By Type - Global Dravet Syndrome Thereapeutics Revenue, 2023-2028
  4.2.3 By Type - Global Dravet Syndrome Thereapeutics Revenue Market Share, 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Dravet Syndrome Thereapeutics Market Size, 2021 & 2028
  5.1.2 Clinic
  5.1.3 Hospital
  5.1.4 Others
5.2 By Application - Global Dravet Syndrome Thereapeutics Revenue & Forecasts
  5.2.1 By Application - Global Dravet Syndrome Thereapeutics Revenue, 2017-2022
  5.2.2 By Application - Global Dravet Syndrome Thereapeutics Revenue, 2023-2028
  5.2.3 By Application - Global Dravet Syndrome Thereapeutics Revenue Market Share, 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Dravet Syndrome Thereapeutics Market Size, 2021 & 2028
6.2 By Region - Global Dravet Syndrome Thereapeutics Revenue & Forecasts
  6.2.1 By Region - Global Dravet Syndrome Thereapeutics Revenue, 2017-2022
  6.2.2 By Region - Global Dravet Syndrome Thereapeutics Revenue, 2023-2028
  6.2.3 By Region - Global Dravet Syndrome Thereapeutics Revenue Market Share, 2017-2028
6.3 North America
  6.3.1 By Country - North America Dravet Syndrome Thereapeutics Revenue, 2017-2028
  6.3.2 US Dravet Syndrome Thereapeutics Market Size, 2017-2028
  6.3.3 Canada Dravet Syndrome Thereapeutics Market Size, 2017-2028
  6.3.4 Mexico Dravet Syndrome Thereapeutics Market Size, 2017-2028
6.4 Europe
  6.4.1 By Country - Europe Dravet Syndrome Thereapeutics Revenue, 2017-2028
  6.4.2 Germany Dravet Syndrome Thereapeutics Market Size, 2017-2028
  6.4.3 France Dravet Syndrome Thereapeutics Market Size, 2017-2028
  6.4.4 U.K. Dravet Syndrome Thereapeutics Market Size, 2017-2028
  6.4.5 Italy Dravet Syndrome Thereapeutics Market Size, 2017-2028
  6.4.6 Russia Dravet Syndrome Thereapeutics Market Size, 2017-2028
  6.4.7 Nordic Countries Dravet Syndrome Thereapeutics Market Size, 2017-2028
  6.4.8 Benelux Dravet Syndrome Thereapeutics Market Size, 2017-2028
6.5 Asia
  6.5.1 By Region - Asia Dravet Syndrome Thereapeutics Revenue, 2017-2028
  6.5.2 China Dravet Syndrome Thereapeutics Market Size, 2017-2028
  6.5.3 Japan Dravet Syndrome Thereapeutics Market Size, 2017-2028
  6.5.4 South Korea Dravet Syndrome Thereapeutics Market Size, 2017-2028
  6.5.5 Southeast Asia Dravet Syndrome Thereapeutics Market Size, 2017-2028
  6.5.6 India Dravet Syndrome Thereapeutics Market Size, 2017-2028
6.6 South America
  6.6.1 By Country - South America Dravet Syndrome Thereapeutics Revenue, 2017-2028
  6.6.2 Brazil Dravet Syndrome Thereapeutics Market Size, 2017-2028
  6.6.3 Argentina Dravet Syndrome Thereapeutics Market Size, 2017-2028
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Dravet Syndrome Thereapeutics Revenue, 2017-2028
  6.7.2 Turkey Dravet Syndrome Thereapeutics Market Size, 2017-2028
  6.7.3 Israel Dravet Syndrome Thereapeutics Market Size, 2017-2028
  6.7.4 Saudi Arabia Dravet Syndrome Thereapeutics Market Size, 2017-2028
  6.7.5 UAE Dravet Syndrome Thereapeutics Market Size, 2017-2028

7 PLAYERS PROFILES

7.1 Biscayne Pharmaceuticals, Inc.
  7.1.1 Biscayne Pharmaceuticals, Inc. Corporate Summary
  7.1.2 Biscayne Pharmaceuticals, Inc. Business Overview
  7.1.3 Biscayne Pharmaceuticals, Inc. Dravet Syndrome Thereapeutics Major Product Offerings
  7.1.4 Biscayne Pharmaceuticals, Inc. Dravet Syndrome Thereapeutics Revenue in Global Market (2017-2022)
  7.1.5 Biscayne Pharmaceuticals, Inc. Key News
7.2 GW Pharmaceuticals Plc
  7.2.1 GW Pharmaceuticals Plc Corporate Summary
  7.2.2 GW Pharmaceuticals Plc Business Overview
  7.2.3 GW Pharmaceuticals Plc Dravet Syndrome Thereapeutics Major Product Offerings
  7.2.4 GW Pharmaceuticals Plc Dravet Syndrome Thereapeutics Revenue in Global Market (2017-2022)
  7.2.5 GW Pharmaceuticals Plc Key News
7.3 INSYS Therapeutics, Inc.
  7.3.1 INSYS Therapeutics, Inc. Corporate Summary
  7.3.2 INSYS Therapeutics, Inc. Business Overview
  7.3.3 INSYS Therapeutics, Inc. Dravet Syndrome Thereapeutics Major Product Offerings
  7.3.4 INSYS Therapeutics, Inc. Dravet Syndrome Thereapeutics Revenue in Global Market (2017-2022)
  7.3.5 INSYS Therapeutics, Inc. Key News
7.4 OPKO Health, Inc.
  7.4.1 OPKO Health, Inc. Corporate Summary
  7.4.2 OPKO Health, Inc. Business Overview
  7.4.3 OPKO Health, Inc. Dravet Syndrome Thereapeutics Major Product Offerings
  7.4.4 OPKO Health, Inc. Dravet Syndrome Thereapeutics Revenue in Global Market (2017-2022)
  7.4.5 OPKO Health, Inc. Key News
7.5 PTC Therapeutics, Inc.
  7.5.1 PTC Therapeutics, Inc. Corporate Summary
  7.5.2 PTC Therapeutics, Inc. Business Overview
  7.5.3 PTC Therapeutics, Inc. Dravet Syndrome Thereapeutics Major Product Offerings
  7.5.4 PTC Therapeutics, Inc. Dravet Syndrome Thereapeutics Revenue in Global Market (2017-2022)
  7.5.5 PTC Therapeutics, Inc. Key News
7.6 Sage Therapeutics, Inc.
  7.6.1 Sage Therapeutics, Inc. Corporate Summary
  7.6.2 Sage Therapeutics, Inc. Business Overview
  7.6.3 Sage Therapeutics, Inc. Dravet Syndrome Thereapeutics Major Product Offerings
  7.6.4 Sage Therapeutics, Inc. Dravet Syndrome Thereapeutics Revenue in Global Market (2017-2022)
  7.6.5 Sage Therapeutics, Inc. Key News
7.7 Xenon Pharmaceuticals Inc.
  7.7.1 Xenon Pharmaceuticals Inc. Corporate Summary
  7.7.2 Xenon Pharmaceuticals Inc. Business Overview
  7.7.3 Xenon Pharmaceuticals Inc. Dravet Syndrome Thereapeutics Major Product Offerings
  7.7.4 Xenon Pharmaceuticals Inc. Dravet Syndrome Thereapeutics Revenue in Global Market (2017-2022)
  7.7.5 Xenon Pharmaceuticals Inc. Key News
7.8 Zogenix, Inc.
  7.8.1 Zogenix, Inc. Corporate Summary
  7.8.2 Zogenix, Inc. Business Overview
  7.8.3 Zogenix, Inc. Dravet Syndrome Thereapeutics Major Product Offerings
  7.8.4 Zogenix, Inc. Dravet Syndrome Thereapeutics Revenue in Global Market (2017-2022)
  7.8.5 Zogenix, Inc. Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Dravet Syndrome Thereapeutics Market Opportunities & Trends in Global Market
Table 2. Dravet Syndrome Thereapeutics Market Drivers in Global Market
Table 3. Dravet Syndrome Thereapeutics Market Restraints in Global Market
Table 4. Key Players of Dravet Syndrome Thereapeutics in Global Market
Table 5. Top Dravet Syndrome Thereapeutics Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Dravet Syndrome Thereapeutics Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Dravet Syndrome Thereapeutics Revenue Share by Companies, 2017-2022
Table 8. Global Companies Dravet Syndrome Thereapeutics Product Type
Table 9. List of Global Tier 1 Dravet Syndrome Thereapeutics Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Dravet Syndrome Thereapeutics Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Dravet Syndrome Thereapeutics Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Dravet Syndrome Thereapeutics Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Dravet Syndrome Thereapeutics Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Dravet Syndrome Thereapeutics Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Dravet Syndrome Thereapeutics Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Dravet Syndrome Thereapeutics Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Dravet Syndrome Thereapeutics Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Dravet Syndrome Thereapeutics Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Dravet Syndrome Thereapeutics Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Dravet Syndrome Thereapeutics Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Dravet Syndrome Thereapeutics Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Dravet Syndrome Thereapeutics Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Dravet Syndrome Thereapeutics Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Dravet Syndrome Thereapeutics Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Dravet Syndrome Thereapeutics Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Dravet Syndrome Thereapeutics Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Dravet Syndrome Thereapeutics Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Dravet Syndrome Thereapeutics Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Dravet Syndrome Thereapeutics Revenue, (US$, Mn), 2023-2028
Table 30. Biscayne Pharmaceuticals, Inc. Corporate Summary
Table 31. Biscayne Pharmaceuticals, Inc. Dravet Syndrome Thereapeutics Product Offerings
Table 32. Biscayne Pharmaceuticals, Inc. Dravet Syndrome Thereapeutics Revenue (US$, Mn), (2017-2022)
Table 33. GW Pharmaceuticals Plc Corporate Summary
Table 34. GW Pharmaceuticals Plc Dravet Syndrome Thereapeutics Product Offerings
Table 35. GW Pharmaceuticals Plc Dravet Syndrome Thereapeutics Revenue (US$, Mn), (2017-2022)
Table 36. INSYS Therapeutics, Inc. Corporate Summary
Table 37. INSYS Therapeutics, Inc. Dravet Syndrome Thereapeutics Product Offerings
Table 38. INSYS Therapeutics, Inc. Dravet Syndrome Thereapeutics Revenue (US$, Mn), (2017-2022)
Table 39. OPKO Health, Inc. Corporate Summary
Table 40. OPKO Health, Inc. Dravet Syndrome Thereapeutics Product Offerings
Table 41. OPKO Health, Inc. Dravet Syndrome Thereapeutics Revenue (US$, Mn), (2017-2022)
Table 42. PTC Therapeutics, Inc. Corporate Summary
Table 43. PTC Therapeutics, Inc. Dravet Syndrome Thereapeutics Product Offerings
Table 44. PTC Therapeutics, Inc. Dravet Syndrome Thereapeutics Revenue (US$, Mn), (2017-2022)
Table 45. Sage Therapeutics, Inc. Corporate Summary
Table 46. Sage Therapeutics, Inc. Dravet Syndrome Thereapeutics Product Offerings
Table 47. Sage Therapeutics, Inc. Dravet Syndrome Thereapeutics Revenue (US$, Mn), (2017-2022)
Table 48. Xenon Pharmaceuticals Inc. Corporate Summary
Table 49. Xenon Pharmaceuticals Inc. Dravet Syndrome Thereapeutics Product Offerings
Table 50. Xenon Pharmaceuticals Inc. Dravet Syndrome Thereapeutics Revenue (US$, Mn), (2017-2022)
Table 51. Zogenix, Inc. Corporate Summary
Table 52. Zogenix, Inc. Dravet Syndrome Thereapeutics Product Offerings
Table 53. Zogenix, Inc. Dravet Syndrome Thereapeutics Revenue (US$, Mn), (2017-2022)

List Of Figures

LIST OF FIGURES

Figure 1. Dravet Syndrome Thereapeutics Segment by Type in 2021
Figure 2. Dravet Syndrome Thereapeutics Segment by Application in 2021
Figure 3. Global Dravet Syndrome Thereapeutics Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Dravet Syndrome Thereapeutics Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Dravet Syndrome Thereapeutics Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Dravet Syndrome Thereapeutics Revenue in 2021
Figure 8. By Type - Global Dravet Syndrome Thereapeutics Revenue Market Share, 2017-2028
Figure 9. By Application - Global Dravet Syndrome Thereapeutics Revenue Market Share, 2017-2028
Figure 10. By Region - Global Dravet Syndrome Thereapeutics Revenue Market Share, 2017-2028
Figure 11. By Country - North America Dravet Syndrome Thereapeutics Revenue Market Share, 2017-2028
Figure 12. US Dravet Syndrome Thereapeutics Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Dravet Syndrome Thereapeutics Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Dravet Syndrome Thereapeutics Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Dravet Syndrome Thereapeutics Revenue Market Share, 2017-2028
Figure 16. Germany Dravet Syndrome Thereapeutics Revenue, (US$, Mn), 2017-2028
Figure 17. France Dravet Syndrome Thereapeutics Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Dravet Syndrome Thereapeutics Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Dravet Syndrome Thereapeutics Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Dravet Syndrome Thereapeutics Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Dravet Syndrome Thereapeutics Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Dravet Syndrome Thereapeutics Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Dravet Syndrome Thereapeutics Revenue Market Share, 2017-2028
Figure 24. China Dravet Syndrome Thereapeutics Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Dravet Syndrome Thereapeutics Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Dravet Syndrome Thereapeutics Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Dravet Syndrome Thereapeutics Revenue, (US$, Mn), 2017-2028
Figure 28. India Dravet Syndrome Thereapeutics Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Dravet Syndrome Thereapeutics Revenue Market Share, 2017-2028
Figure 30. Brazil Dravet Syndrome Thereapeutics Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Dravet Syndrome Thereapeutics Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Dravet Syndrome Thereapeutics Revenue Market Share, 2017-2028
Figure 33. Turkey Dravet Syndrome Thereapeutics Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Dravet Syndrome Thereapeutics Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Dravet Syndrome Thereapeutics Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Dravet Syndrome Thereapeutics Revenue, (US$, Mn), 2017-2028
Figure 37. Biscayne Pharmaceuticals, Inc. Dravet Syndrome Thereapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. GW Pharmaceuticals Plc Dravet Syndrome Thereapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. INSYS Therapeutics, Inc. Dravet Syndrome Thereapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. OPKO Health, Inc. Dravet Syndrome Thereapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. PTC Therapeutics, Inc. Dravet Syndrome Thereapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Sage Therapeutics, Inc. Dravet Syndrome Thereapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Xenon Pharmaceuticals Inc. Dravet Syndrome Thereapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. Zogenix, Inc. Dravet Syndrome Thereapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)